User profiles for Eirini Vasarmidi
 | EIRINI VASARMIDIDpt of Respiratory Medicine and Laboratory of Molecular and Cellular Pneumonology … Verified email at inserm.fr Cited by 1179 |
[HTML][HTML] Pulmonary fibrosis in the aftermath of the COVID-19 era
E Vasarmidi, E Tsitoura… - Experimental …, 2020 - … .spandidos-publications.com
The year 2020 is characterized by the COVID‑19 pandemic that has resulted in more than
half a million deaths in recent months. The high mortality is associated with acute severe …
half a million deaths in recent months. The high mortality is associated with acute severe …
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
The landscape of idiopathic pulmonary fibrosis (IPF) has changed. The significant progress
regarding our knowledge on the pathogenesis of the disease together with the experience …
regarding our knowledge on the pathogenesis of the disease together with the experience …
Smoking and interstitial lung diseases
GA Margaritopoulos, E Vasarmidi… - European …, 2015 - Eur Respiratory Soc
For many years has been well known that smoking could cause lung damage. Chronic
obstructive pulmonary disease and lung cancer have been the two most common smoking-…
obstructive pulmonary disease and lung cancer have been the two most common smoking-…
[HTML][HTML] European Respiratory Society statement on long COVID follow-up
Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung
…, C Choulaki, E Vasarmidi… - European …, 2016 - Eur Respiratory Soc
In this study we investigated the implication of NLRP3 inflammasomes in the pathogenesis
of idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis–usual interstitial pneumonia (…
of idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis–usual interstitial pneumonia (…
[HTML][HTML] Enhanced IL-1β release following NLRP3 and AIM2 inflammasome stimulation is linked to mtROS in airway macrophages in pulmonary fibrosis
…, S Mastrodimou, R Invernizzi, E Vasarmidi… - Frontiers in …, 2021 - frontiersin.org
Fibrotic Interstitial lung diseases (ILDs) are complex disorders of variable clinical behaviour.
The majority of them cause significant morbidity, whilst Idiopathic Pulmonary Fibrosis (IPF) …
The majority of them cause significant morbidity, whilst Idiopathic Pulmonary Fibrosis (IPF) …
[HTML][HTML] Pirfenidone improves survival in IPF: results from a real-life study
…, A Trachalaki, AU Wells, E Vasarmidi… - BMC pulmonary …, 2018 - Springer
Background Pirfenidone is an antifibrotic compound approved for the treatment of idiopathic
pulmonary fibrosis (IPF). We present our real-world experience in terms of Pirfenidone’s …
pulmonary fibrosis (IPF). We present our real-world experience in terms of Pirfenidone’s …
[HTML][HTML] Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
…, A Tzouvelekis, A Trachalaki, E Vasarmidi… - ERJ open …, 2020 - Eur Respiratory Soc
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary
fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated …
fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated …
[HTML][HTML] Collagen 1a1 expression by airway macrophages increases in fibrotic ILDs and is associated with FVC decline and increased mortality
E Tsitoura, A Trachalaki, E Vasarmidi… - Frontiers in …, 2021 - frontiersin.org
Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF)
and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of …
and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of …
[HTML][HTML] Accumulation of damaged mitochondria in alveolar macrophages with reduced OXPHOS related gene expression in IPF
E Tsitoura, E Vasarmidi, E Bibaki, A Trachalaki… - Respiratory …, 2019 - Springer
Background Impaired mitochondria homeostasis and function are established hallmarks of
aging and increasing evidence suggests a link with lung fibrosis. Mitochondria homeostasis …
aging and increasing evidence suggests a link with lung fibrosis. Mitochondria homeostasis …